3rd Quarter - Report

TIBER CREEK GROUP for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to the pharmaceutical sales fee for Medicare Part B. Issues related to the renewal of the R&D tax credit.

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
SHEILA MURPHY —
SEAN RICHARDSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Issues related to S.23/H.R. 1249, America Invents Act.

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
SHEILA MURPHY —
SEAN RICHARDSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1249 (112th), S. 23 (112th)

Health Issues HCR

Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to the supply of medical isotopes (S. 99, the American Medical Isotopes Production Act). Issues related to reauthorization of the Prescription Drug User Fee Act. Issues related to cancer research and treatment. Issues related to drug safety.

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
SHEILA MURPHY —
SEAN RICHARDSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 99 (112th)

Medicare/Medicaid MMM

Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
SHEILA MURPHY —
SEAN RICHARDSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.